These effects, along with a earlier report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 aid the concept of targeting ACKR3 as a novel solution to modulate the opioid procedure, which could open new therapeutic avenues for opioid-relevant Diseases.“Over-all, the discovery of the prospective mode of